Tags

Type your tag names separated by a space and hit enter

Severe Covid-19.
N Engl J Med. 2020 Dec 17; 383(25):2451-2460.NEJM

Links

Publisher Full Text (DOI)

Authors+Show Affiliations

Berlin DA
From Weill Cornell Medicine, New York.
Gulick RM
From Weill Cornell Medicine, New York.
Martinez FJ
From Weill Cornell Medicine, New York.

MeSH

Adenosine MonophosphateAlanineAnti-Inflammatory AgentsAntiviral AgentsBrainCOVID-19COVID-19 TestingDexamethasoneDyspneaHumansLungMaleMiddle AgedPatient AcuityRadiography, ThoracicRespiration, ArtificialRespiratory Distress SyndromeSARS-CoV-2Tomography, X-Ray Computed

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

32412710

Clinical Trial Links

Current Pharmacological Practices in Severe COVID-19

Citation

Berlin, David A., et al. "Severe Covid-19." The New England Journal of Medicine, vol. 383, no. 25, 2020, pp. 2451-2460.
Berlin DA, Gulick RM, Martinez FJ. Severe Covid-19. N Engl J Med. 2020;383(25):2451-2460.
Berlin, D. A., Gulick, R. M., & Martinez, F. J. (2020). Severe Covid-19. The New England Journal of Medicine, 383(25), 2451-2460. https://doi.org/10.1056/NEJMcp2009575
Berlin DA, Gulick RM, Martinez FJ. Severe Covid-19. N Engl J Med. 2020 Dec 17;383(25):2451-2460. PubMed PMID: 32412710.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Severe Covid-19. AU - Berlin,David A, AU - Gulick,Roy M, AU - Martinez,Fernando J, Y1 - 2020/05/15/ PY - 2020/5/16/pubmed PY - 2020/12/29/medline PY - 2020/5/16/entrez SP - 2451 EP - 2460 JF - The New England journal of medicine JO - N Engl J Med VL - 383 IS - 25 SN - 1533-4406 UR - https://www.unboundmedicine.com/medline/citation/32412710/full_citation DB - PRIME DP - Unbound Medicine ER -